Starlix (Nateglinide) - Current Clinical Trials

Starlix Related Clinical Trials

Study of the Durability of Glycemic Control With Nateglinide [Recruiting]

Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion: Optimal Glycemic Control [Recruiting]

Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients [Completed]

Effects of Nateglinide vs. Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia and Inflammatory Factors [Recruiting]

A Pilot Study to Evaluate the Effects of Nateglinide Vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion [Completed]

The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients [Completed]

Long-Term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications [Active, not recruiting]

Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone [Completed]

Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients [Completed]

MK-3102 Phase III Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015) [Recruiting]

Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients [Active, not recruiting]

Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference? [Recruiting]

Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes [Completed]

Combination of Glinides With Premixed Insulin [Completed]